Novel hormone replacement therapy trial demonstrates improved memory function in adrenal patients

Better timing for cortisol replacement therapies, to more closely replicate the secretion patterns of people with normal levels of the hormone, has shown a significant improvement in patients' cognitive function. This is the striking finding from a new trial led by University of Bristol scientists including Professor Stafford Lightman and published in the Proceedings of the National Academy of Science (PNAS). The findings are potentially important and underline the case for novel therapeutic approaches, as patients on cortisol replacement therapy often have side effects that make it difficult for them to lead normal lives.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news